Logo image of C5H.I

CAIRN HOMES PLC (C5H.I) Stock Fundamental Analysis

Europe - DUB:C5H - IE00BWY4ZF18 - Common Stock

1.918 EUR
-0.04 (-1.84%)
Last: 9/26/2025, 7:00:00 PM
Fundamental Rating

6

C5H gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 33 industry peers in the Household Durables industry. C5H has an excellent profitability rating, but there are some minor concerns on its financial health. C5H is not valued too expensively and it also shows a decent growth rate. C5H also has an excellent dividend rating. This makes C5H very considerable for dividend investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year C5H was profitable.
In the past year C5H has reported a negative cash flow from operations.
Each year in the past 5 years C5H has been profitable.
Of the past 5 years C5H 4 years had a positive operating cash flow.
C5H.I Yearly Net Income VS EBIT VS OCF VS FCFC5H.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of 7.73%, C5H belongs to the top of the industry, outperforming 84.85% of the companies in the same industry.
The Return On Equity of C5H (13.01%) is better than 75.76% of its industry peers.
C5H's Return On Invested Capital of 10.12% is fine compared to the rest of the industry. C5H outperforms 75.76% of its industry peers.
The Average Return On Invested Capital over the past 3 years for C5H is in line with the industry average of 10.00%.
Industry RankSector Rank
ROA 7.73%
ROE 13.01%
ROIC 10.12%
ROA(3y)8.93%
ROA(5y)6.46%
ROE(3y)12.39%
ROE(5y)8.88%
ROIC(3y)11.22%
ROIC(5y)8.33%
C5H.I Yearly ROA, ROE, ROICC5H.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

C5H's Profit Margin of 12.77% is amongst the best of the industry. C5H outperforms 93.94% of its industry peers.
In the last couple of years the Profit Margin of C5H has grown nicely.
C5H's Operating Margin of 16.87% is amongst the best of the industry. C5H outperforms 93.94% of its industry peers.
C5H's Operating Margin has improved in the last couple of years.
C5H's Gross Margin of 21.81% is on the low side compared to the rest of the industry. C5H is outperformed by 78.79% of its industry peers.
In the last couple of years the Gross Margin of C5H has grown nicely.
Industry RankSector Rank
OM 16.87%
PM (TTM) 12.77%
GM 21.81%
OM growth 3Y8.2%
OM growth 5Y2.23%
PM growth 3Y9.36%
PM growth 5Y2.53%
GM growth 3Y3.19%
GM growth 5Y2.1%
C5H.I Yearly Profit, Operating, Gross MarginsC5H.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

6

2. Health

2.1 Basic Checks

C5H has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for C5H has been reduced compared to 1 year ago.
C5H has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, C5H has a worse debt to assets ratio.
C5H.I Yearly Shares OutstandingC5H.I Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
C5H.I Yearly Total Debt VS Total AssetsC5H.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 3.98 indicates that C5H is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 3.98, C5H belongs to the best of the industry, outperforming 87.88% of the companies in the same industry.
A Debt/Equity ratio of 0.45 indicates that C5H is not too dependend on debt financing.
C5H's Debt to Equity ratio of 0.45 is in line compared to the rest of the industry. C5H outperforms 51.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 3.98
ROIC/WACC1.35
WACC7.49%
C5H.I Yearly LT Debt VS Equity VS FCFC5H.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

2.3 Liquidity

C5H has a Current Ratio of 7.09. This indicates that C5H is financially healthy and has no problem in meeting its short term obligations.
C5H has a better Current ratio (7.09) than 100.00% of its industry peers.
C5H has a Quick Ratio of 1.28. This is a normal value and indicates that C5H is financially healthy and should not expect problems in meeting its short term obligations.
C5H has a Quick ratio of 1.28. This is amongst the best in the industry. C5H outperforms 81.82% of its industry peers.
Industry RankSector Rank
Current Ratio 7.09
Quick Ratio 1.28
C5H.I Yearly Current Assets VS Current LiabilitesC5H.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

C5H shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.00%.
C5H shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 20.48% yearly.
C5H shows a decrease in Revenue. In the last year, the revenue decreased by -4.33%.
The Revenue has been growing by 14.59% on average over the past years. This is quite good.
EPS 1Y (TTM)-7%
EPS 3Y43.61%
EPS 5Y20.48%
EPS Q2Q%-29.5%
Revenue 1Y (TTM)-4.33%
Revenue growth 3Y26.58%
Revenue growth 5Y14.59%
Sales Q2Q%-22.31%

3.2 Future

Based on estimates for the next years, C5H will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.67% on average per year.
C5H is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.57% yearly.
EPS Next Y11.67%
EPS Next 2Y11.06%
EPS Next 3Y8.67%
EPS Next 5YN/A
Revenue Next Year10.82%
Revenue Next 2Y8.51%
Revenue Next 3Y6.57%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
C5H.I Yearly Revenue VS EstimatesC5H.I Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
C5H.I Yearly EPS VS EstimatesC5H.I Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 0.1 0.15 0.2

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.99, which indicates a very decent valuation of C5H.
69.70% of the companies in the same industry are more expensive than C5H, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.32, C5H is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 8.39, the valuation of C5H can be described as reasonable.
C5H's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. C5H is cheaper than 72.73% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.89, C5H is valued rather cheaply.
Industry RankSector Rank
PE 11.99
Fwd PE 8.39
C5H.I Price Earnings VS Forward Price EarningsC5H.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

C5H's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. C5H is more expensive than 63.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.46
C5H.I Per share dataC5H.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

C5H's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of C5H may justify a higher PE ratio.
PEG (NY)1.03
PEG (5Y)0.59
EPS Next 2Y11.06%
EPS Next 3Y8.67%

7

5. Dividend

5.1 Amount

C5H has a Yearly Dividend Yield of 4.35%, which is a nice return.
Compared to an average industry Dividend Yield of 4.59, C5H pays a bit more dividend than its industry peers.
C5H's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 4.35%

5.2 History

The dividend of C5H is nicely growing with an annual growth rate of 23.30%!
Dividend Growth(5Y)23.3%
Div Incr Years3
Div Non Decr Years3
C5H.I Yearly Dividends per shareC5H.I Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.02 0.04 0.06

5.3 Sustainability

51.93% of the earnings are spent on dividend by C5H. This is a bit on the high side, but may be sustainable.
The dividend of C5H is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP51.93%
EPS Next 2Y11.06%
EPS Next 3Y8.67%
C5H.I Yearly Income VS Free CF VS DividendC5H.I Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M
C5H.I Dividend Payout.C5H.I Dividend Payout, showing the Payout Ratio.C5H.I Dividend Payout.PayoutRetained Earnings

CAIRN HOMES PLC

DUB:C5H (9/26/2025, 7:00:00 PM)

1.918

-0.04 (-1.84%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)09-03 2025-09-03
Earnings (Next)02-25 2026-02-25/amc
Inst Owners80.15%
Inst Owner ChangeN/A
Ins Owners3.77%
Ins Owner ChangeN/A
Market Cap1.20B
Analysts83.64
Price Target2.52 (31.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.35%
Yearly Dividend0.07
Dividend Growth(5Y)23.3%
DP51.93%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.11%
PT rev (3m)-2.53%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE 11.99
Fwd PE 8.39
P/S 1.54
P/FCF N/A
P/OCF N/A
P/B 1.57
P/tB 1.58
EV/EBITDA 11.46
EPS(TTM)0.16
EY8.34%
EPS(NY)0.23
Fwd EY11.92%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS1.24
BVpS1.22
TBVpS1.21
PEG (NY)1.03
PEG (5Y)0.59
Profitability
Industry RankSector Rank
ROA 7.73%
ROE 13.01%
ROCE 11.85%
ROIC 10.12%
ROICexc 10.54%
ROICexgc 10.58%
OM 16.87%
PM (TTM) 12.77%
GM 21.81%
FCFM N/A
ROA(3y)8.93%
ROA(5y)6.46%
ROE(3y)12.39%
ROE(5y)8.88%
ROIC(3y)11.22%
ROIC(5y)8.33%
ROICexc(3y)11.53%
ROICexc(5y)8.59%
ROICexgc(3y)11.58%
ROICexgc(5y)8.63%
ROCE(3y)13.13%
ROCE(5y)9.75%
ROICexcg growth 3Y32.35%
ROICexcg growth 5Y16.05%
ROICexc growth 3Y32.21%
ROICexc growth 5Y15.96%
OM growth 3Y8.2%
OM growth 5Y2.23%
PM growth 3Y9.36%
PM growth 5Y2.53%
GM growth 3Y3.19%
GM growth 5Y2.1%
F-Score2
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA 2.55
Cap/Depr 127.6%
Cap/Sales 0.45%
Interest Coverage 11.65
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.09
Quick Ratio 1.28
Altman-Z 3.98
F-Score2
WACC7.49%
ROIC/WACC1.35
Cap/Depr(3y)261.68%
Cap/Depr(5y)199.51%
Cap/Sales(3y)0.79%
Cap/Sales(5y)0.56%
Profit Quality(3y)113.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7%
EPS 3Y43.61%
EPS 5Y20.48%
EPS Q2Q%-29.5%
EPS Next Y11.67%
EPS Next 2Y11.06%
EPS Next 3Y8.67%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.33%
Revenue growth 3Y26.58%
Revenue growth 5Y14.59%
Sales Q2Q%-22.31%
Revenue Next Year10.82%
Revenue Next 2Y8.51%
Revenue Next 3Y6.57%
Revenue Next 5YN/A
EBIT growth 1Y-9.57%
EBIT growth 3Y36.95%
EBIT growth 5Y17.14%
EBIT Next Year9.34%
EBIT Next 3Y5.93%
EBIT Next 5YN/A
FCF growth 1Y-144.37%
FCF growth 3Y14.39%
FCF growth 5Y5.88%
OCF growth 1Y-137.25%
OCF growth 3Y15.01%
OCF growth 5Y6.31%